FEATURE: Obtaining reimbursement for innovative products in Europe
This article was originally published in Clinica
Executive Summary
What are the options for manufacturers to receive reimbursement for technologies that do not yet have an appropriate code within national European reimbursement systems? That is the question addressed in this article, the second in a series by Carolyn Semple Piggot and colleagues at the UK-based Translucency network